CEVA, Inc. (CEVA) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts CEVA Hot Sheet
Join SI Premium – FREE
CEVA, Inc. (NASDAQ: CEVA) reported Q3 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $14.1 million versus the consensus estimate of $13.85 million.
For earnings history and earnings-related data on CEVA, Inc. (CEVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CEVA Inc. (CEVA) PT Lowered to $45 at TD Cowen
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
